Oncolytic viruses: newest frontier for cancer immunotherapy

MM Rahman, G McFadden - Cancers, 2021 - mdpi.com
Simple Summary Oncolytic viruses (OVs) are viruses that selectively target and kill cancer
cells while sparing normal ones. OVs are from diverse families of viruses, but naturally …

Oncolytic viruses: challenges and considerations in an evolving clinical landscape

UM Lauer, J Beil - Future Oncology, 2022 - Taylor & Francis
Despite advances in treatment, cancer remains a leading cause of death worldwide.
Although treatment strategies are continually progressing, cancers have evolved many …

[HTML][HTML] Targeting the tumor microenvironment: Potential strategy for cancer therapeutics

Q Babar, A Saeed, TA Tabish, M Sarwar… - Biochimica et Biophysica …, 2023 - Elsevier
Cellular and stromal components including tumor cells, immune cells, mesenchymal cells,
cancer-linked fibroblasts, and extracellular matrix, constituent tumor microenvironment …

Oncolytic viruses-modulated immunogenic cell death, apoptosis and autophagy linking to virotherapy and cancer immune response

YY Wu, TK Sun, MS Chen, M Munir… - Frontiers in Cellular and …, 2023 - frontiersin.org
Recent reports have revealed that oncolytic viruses (OVs) play a significant role in cancer
therapy. The infection of OVs such as oncolytic vaccinia virus (OVV), vesicular stomatitis …

Nanocarriers: a reliable tool for the delivery of anticancer drugs

H Sabit, M Abdel-Hakeem, T Shoala, S Abdel-Ghany… - Pharmaceutics, 2022 - mdpi.com
Nanomedicines have gained popularity due to their potential therapeutic applications,
especially cancer treatment. Targeted nanoparticles can deliver drugs directly to cancer …

Oncolytic viruses combined with immune checkpoint therapy for colorectal cancer is a promising treatment option

Y Ren, JM Miao, YY Wang, Z Fan, XB Kong… - Frontiers in …, 2022 - frontiersin.org
Immunotherapy is one of the promising strategies in the treatment of oncology. Immune
checkpoint inhibitors, as a type of immunotherapy, have no significant efficacy in the clinical …

Oncolytic adenovirus promotes vascular normalization and nonclassical tertiary lymphoid structure formation through STING-mediated DC activation

T He, Z Hao, M Lin, Z **n, Y Chen, W Ouyang… - …, 2022 - Taylor & Francis
Inducing a full antitumor immune response in the tumor microenvironment (TME) is essential
for successful cancer immunotherapy. Here, we report that an oncolytic adenovirus carrying …

Immunovirotherapy: The role of antibody based therapeutics combination with oncolytic viruses

M Jafari, M Kadkhodazadeh… - Frontiers in …, 2022 - frontiersin.org
Despite the fact that the new drugs and targeted therapies have been approved for cancer
therapy during the past 30 years, the majority of cancer types are still remain challenging to …

[HTML][HTML] MiRNA-Mediated Mechanisms in the Generation of Effective and Safe Oncolytic Viruses

M Toropko, S Chuvpilo, A Karabelsky - Pharmaceutics, 2024 - mdpi.com
MicroRNAs (miRNAs) are short non-coding RNAs that regulate gene expression by
inhibiting the translation of target transcripts. The expression profiles of miRNAs vary in …

Hypoxia effects on oncolytic virotherapy in Cancer: Friend or Foe?

M Sadri, A Najafi, A Rahimi, N Behranvand… - International …, 2023 - Elsevier
Researchers have tried to find novel strategies for cancer treatment in the past decades.
Among the utilized methods, administering oncolytic viruses (OVs) alone or combined with …